Taylor Zac, Keating Kevin, Rohloff Matthew, Maatman Thomas J
Burrell College of Osteopathic Medicine, Las Cruces, NM, USA.
Department of Urological Surgery, Metro Health, University of Michigan Health, Grand Rapids, MI, USA.
J Robot Surg. 2020 Dec;14(6):855-859. doi: 10.1007/s11701-020-01060-z. Epub 2020 Mar 5.
The gold standard for urologic management of large stone disease traditionally has been percutaneous nephrolithotomy (PCNL). An alternative to PCNL is robotic pyelolithotomy (RP), which continues to gain traction. This study is a retrospective review of ten cases performed over a 2 year period presenting operative outcomes for large stone disease treated with RP. The mean and standard deviation were calculated for age, body mass index, stone volume, stone diameter, pre-operative creatinine, operative time, robot-docked time, length of stay, post-operative creatinine, and estimated blood loss. In addition, results were collected for post-operative complications and secondary procedure requirements. Complete stone clearance was successful in 9 of 10 cases. The average renal function remained stable from a pre-operative creatinine of 0.917 mg/dL to a post-operative creatinine level of 0.943 mg/dL. This case series demonstrates that robotic assisted surgery has practical application when managing large stone disease.
传统上,经皮肾镜取石术(PCNL)一直是治疗大型结石疾病的泌尿外科管理的金标准。PCNL的一种替代方法是机器人肾盂切开取石术(RP),该方法越来越受到关注。本研究是一项回顾性研究,回顾了在2年期间进行的10例采用RP治疗大型结石疾病的手术结果。计算了年龄、体重指数、结石体积、结石直径、术前肌酐、手术时间、机器人对接时间、住院时间、术后肌酐和估计失血量的平均值和标准差。此外,还收集了术后并发症和二次手术需求的结果。10例患者中有9例成功实现了结石完全清除。肾功能平均保持稳定,术前肌酐水平为0.917mg/dL,术后肌酐水平为0.943mg/dL。该病例系列表明,机器人辅助手术在治疗大型结石疾病时具有实际应用价值。